Image Presentation
Research Article
Case Report
Aim & Scope
The journal covers the articles about the included fields and will focus on innovations and new developments. All the articles about Imaging in Oncology will be accepted in case of including new advances.
The main topic of this journal is Oncologic Imaging and the journal will accept articles (original, case reports as well as review articles) in all the fields (Nuclear Medicine, Radiation Oncology and Radiology) about Oncologic Imaging.
The journal covers the articles about the included fields and will focus on innovations and new developments. All the articles about Imaging in Oncology will be accepted in case of including new advances.
The main topic of this journal is Oncologic Imaging and the journal will accept articles (original, case reports as well as review articles) in all the fields (Nuclear Medicine, Radiation Oncology and Radiology) about Oncologic Imaging.
Author Guidelines
Cambria, 9 font size. Abstract should be at most 200 words. Key words that will consist of at least 3 and maximum 5 words should be written on the left side. Mathematical expressions should not be included in essence.
Content should be written in 1 column with Cambria 10 font size. The first line of each paragraph should be written by 0.5 cm indentation.
The article should begin with an introduction section, which includes the ideas and the basic objectives and approaches of the article, combining scientific knowledge, evidence-based information and logical discussions in different disciplines. This section should be written considering all readers. Technical terms, symbols and abbreviations should be defined when first used in the article.
The main sections of the manuscript are “introduction”, “method” “results” “discussion” and “conclusion” and they should be written in 10 font size, justify, bold and capital letters.
All of the empty lines should have 8 font size.
This template explains how to design the manuscript. If the author (s) uses this template file, no settings change will be required since settings such as font and size, line spacing, spaces before paragraphs, indents, etc. are made in styles. If you want to avoid problems when copy and paste texts or with the text format, you can use “Applying styles to the article” section which is at the end of template.
Ethical Principles and Publication Policy
The Ethics standards of this publications include; the publication rights and permissions of the articles are preserved by the Journal. The authors should provide the data of the article for the reference for a reasonable time period. Also the authors are responsible to check for plagiarism and should provide original data. The manuscript that is submitted to journal should not be under consideration of another journal and-or not published previously except for publications as an abstract for a scientific meeting. The suitable citations are in the responsibility of the corresponding
author as well as the special permissions for the sources of the published visual materials (Tables, graphics, images) in case of external use. The coauthors of the article should participate sufficiently to the publication proses and approve of the last version of the manuscript before publication. If the publication includes human or animal subjects the authors should verify the rules and regulations are followed during the preparation of the article and the study was confirmed by an Ethics Committee. All the manuscript should include a financial disclosure and conflict of interest section and acknowledgements should be stated after the conclusion before the references.
Price Policy
Dergi tamamen ücretsizdir.
Indexes
Other Indexes
Journal Boards
Editor
Zehra Pınar KOç
Title : Professor
Department : Faculty of Medicine / Department of Nuclear Medicine
Place of birth : KONYA
Business Address :
Phone : +90-324-2410000
Fax : +90-324-2410098
e-Mail : pinarkoc@mersin.edu.tr
zehrapinarkoc@gmail.com
URL : http://apbs.mersin.edu.tr/pinarkoc
Researcher ID :
Scopus ID :
Orcid ID :
Scholar ID :
h-index :
publons_id :
Point : 29863
Foreign Language : English, iyi, ÜDS, 87
Created : 2015-07-04 07:23:28
Last Modification : 2019-02-11 13:53:16
Academic Degrees
Degree Department/Program Institute Year
MD MEDICAL SCHOOL ANKARA UNIVERSITY 2003
PHYSICIAN NUCLEAR MEDICINE AKDENIZ UNIVERSITY 2008
Theses
Expertise in Medicine Thesis
1. The place of combining ischemia modified albumin (IMA) levels to myocardial perfusion scintigraphy in diagnosis of coronary artery disease.,
Supervisor: Dr. Metin Erkılıç, Akdeniz University, Others, Other Department, Antalya, Turkey, .
Positions Held
Title Institute Year
ASSOC. PROF. DR FIRAT UNIVERSITY 2011-11-11 - 2014-01-27
ASSIST. PROF. DR FIRAT UNIVERSITY 2014-01-28 - 2014-12-30
PROF DR MERSIN UNIVERSITY 2015-01-09 - Continue
Administrative Duties
Title Dutie Institution/Other Year
HEAD OF RADIATION PROTECTION
COMMITTEE
MANAGEMENT OF RADIATION PROTECTION
COMMITTEE
MERSIN UNIVERSITY 2018-07-17 - 2018-12-26
HEAD OF DEPARTMENT HEAD OF DEPARTMENT FIRAT UNIVERSITY 2011-11-30 - 2014-11-30
Co-Editor
Editorial Board
Yıldız Teknik Üniversitesi Biyomühendislik bölümünde Doktora eğitimi almaktayım. Yıldız Teknik Üniversitesi Biyomühendislik bölümünden, çift lisansım olan Moleküler Biyoloji ve Genetik bölümünden ve Anadolu Üniversitesi Sağlık Kurumları İşletmeciliği bölümünden mezun oldum. Ayrıca Yıldız Teknik Üniversitesi Biyomühendislik bölümünde yüksek lisans eğitimimi tamamladım. Yüksek lisans tezimde meme kanserine karşı hibridoma teknolojisine dayalı poliklonal antikor üretimi üzerine çalışmalar yaptım.
Eğitimim sırasında Florence Nightingale Hastanesi biyokimya laboratuvarında ve Bıçakçılar Tıbbi cihazlar A.Ş de tek kullanımlık üretim bölümünde ve Bezmi ALEM Vakıf Üniversitesi Yaşam Bilimleri ve Biyoteknoloji Enstitüsünde rekombinant protein üzerine staj yaptım. Yüksek lisans eğitimim sürecinde hücre kültürü ve doku mühendisliği laboratuvarında hücre kültürü eğitimi (kök hücreleri, kanser hücreleri (MCF-7, AU-595, MDA-MB-231, AGS), immün sistem hücreleri, epitel hücreleri vb.) aldım.
TÜSEB’in desteklediği ‘’Covid-19 Aşı Geliştirme Çalışmalarında Kullanılmak Üzere Antijenik Peptid/Proteinlerden Oluşan Yerli Bir Kütüphanenin Oluşturulması, Spesifik Antijenik Peptid/Proteinlerin Üretimi ve Immun Yanıtı Belirlenmiş Aşı Formülasyonu Eldesi’’ projesinde araştırmacı olarak görev almaktayım. Ayrıca ‘’İnsan Meme Kanserinin Farklı Suşlarına Karşı Tanıya Yönelik Hibridoma Teknolojisine Dayalı Poliklonal Antikorların Üretilmesi’’ adlı NAP Projesinde görev aldım. Şu anda da ‘’Visseral Leishmaniasise Karşı Polikaprolakton Temelli İmmünokemoterapötik Ajanları İçeren Nanopartiküler Taşıyıcı Sistemlerin Geliştirilmesi’’ adlı TÜBİTAK 1003 Projesinde ve ‘’Meme Kanserine Karşı Antijen Yüklü Polimerik Nanopartiküler Aşı Adaylarının Geliştirilmesi’’ adlı GAP Projesinde yer almaktayım. 2022 yılında Biruni Üniversitesinde öğretim görevlisi olarak çalışmaya başlamış olup hala bu kurumda görev yapmaktadır
Saygılarımla,
Murat IHLAMUR
05445240534
Dicle Üniversitesi Tıp Fakültesi’nden mezun olduktan sonra pratisyen doktor olarak çalıştım. Mersin Üniversitesi Sağlık Bilimleri Enstitüsü, Tıbbi Biyoloji ve Genetik Anabilim Dalında 2003- 2006 tarihleri arasında yüksek lisans, 2007- 2012 tarihleri arasında ise doktora yaptım. 2017 yılından beri Mersin Üniversitesi Tıp Fakültesi Tıbbi Genetik AD’nda Dr. Öğr. Üyesi olarak çalışmaktayım
